 | • レポートコード：GIR201106138 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、経口ポリオワクチン（OPV）の世界市場を調査対象にし、経口ポリオワクチン（OPV）の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（三価OPV、二価OPV）、用途別分析（パブリック、プライベート）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Sanofi、Halfkin Bio-Pharmaceuticals、Serum Institute、GSK、Bio-Med、Bibcol、Panacea Biotec Ltd、Tiantan Biological ・メーカー別販売量、売上、市場シェア ・経口ポリオワクチン（OPV）の地域別市場分析 ・経口ポリオワクチン（OPV）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・経口ポリオワクチン（OPV）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・経口ポリオワクチン（OPV）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・経口ポリオワクチン（OPV）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・経口ポリオワクチン（OPV）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・経口ポリオワクチン（OPV）の種類別市場規模2015-2020：三価OPV、二価OPV ・経口ポリオワクチン（OPV）の用途別市場規模2015-2020：パブリック、プライベート ・経口ポリオワクチン（OPV）の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Oral Polio Vaccines (OPV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oral Polio Vaccines (OPV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oral Polio Vaccines (OPV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oral Polio Vaccines (OPV) market has been segmented into
Trivalent OPV
Bivalent OPV
By Application, Oral Polio Vaccines (OPV) has been segmented into:
Public
Private
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Polio Vaccines (OPV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Polio Vaccines (OPV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Polio Vaccines (OPV) market.
The report offers in-depth assessment of the growth and other aspects of the Oral Polio Vaccines (OPV) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oral Polio Vaccines (OPV) Market Share Analysis
Oral Polio Vaccines (OPV) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Polio Vaccines (OPV) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Polio Vaccines (OPV) sales, revenue and market share for each player covered in this report.
The major players covered in Oral Polio Vaccines (OPV) are:
Sanofi
Halfkin Bio-Pharmaceuticals
Serum Institute
GSK
Bio-Med
Bibcol
Panacea Biotec Ltd
Tiantan Biological
Among other players domestic and global, Oral Polio Vaccines (OPV) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Polio Vaccines (OPV) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Polio Vaccines (OPV), with price, sales, revenue and global market share of Oral Polio Vaccines (OPV) in 2018 and 2019.
Chapter 3, the Oral Polio Vaccines (OPV) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Polio Vaccines (OPV) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oral Polio Vaccines (OPV) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oral Polio Vaccines (OPV) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oral Polio Vaccines (OPV) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Polio Vaccines (OPV) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Trivalent OPV
1.2.3 Bivalent OPV
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Polio Vaccines (OPV) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Oral Polio Vaccines (OPV) Market
1.4.1 Global Oral Polio Vaccines (OPV) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Halfkin Bio-Pharmaceuticals
2.2.1 Halfkin Bio-Pharmaceuticals Details
2.2.2 Halfkin Bio-Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Halfkin Bio-Pharmaceuticals SWOT Analysis
2.2.4 Halfkin Bio-Pharmaceuticals Product and Services
2.2.5 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Serum Institute
2.3.1 Serum Institute Details
2.3.2 Serum Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Serum Institute SWOT Analysis
2.3.4 Serum Institute Product and Services
2.3.5 Serum Institute Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Med
2.5.1 Bio-Med Details
2.5.2 Bio-Med Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Med SWOT Analysis
2.5.4 Bio-Med Product and Services
2.5.5 Bio-Med Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bibcol
2.6.1 Bibcol Details
2.6.2 Bibcol Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bibcol SWOT Analysis
2.6.4 Bibcol Product and Services
2.6.5 Bibcol Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Panacea Biotec Ltd SWOT Analysis
2.7.4 Panacea Biotec Ltd Product and Services
2.7.5 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Tiantan Biological
2.8.1 Tiantan Biological Details
2.8.2 Tiantan Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Tiantan Biological SWOT Analysis
2.8.4 Tiantan Biological Product and Services
2.8.5 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oral Polio Vaccines (OPV) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Polio Vaccines (OPV) Manufacturer Market Share in 2019
3.3.2 Top 6 Oral Polio Vaccines (OPV) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Polio Vaccines (OPV) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Regions (2015-2020)
4.2 North America Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
4.3 Europe Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
4.5 South America Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
5.1.1 North America Oral Polio Vaccines (OPV) Sales and Market Share by Country (2015-2020)
5.1.2 North America Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2015-2020)
5.2 United States Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
5.3 Canada Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
5.4 Mexico Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Polio Vaccines (OPV) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2015-2020)
6.2 Germany Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
6.3 UK Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
6.4 France Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
6.5 Russia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
6.6 Italy Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oral Polio Vaccines (OPV) Revenue and Market Share by Regions (2015-2020)
7.2 China Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
7.3 Japan Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
7.4 Korea Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
7.5 India Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
7.7 Australia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
8.1.1 South America Oral Polio Vaccines (OPV) Sales and Market Share by Country (2015-2020)
8.1.2 South America Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
8.3 Argentina Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oral Polio Vaccines (OPV) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
9.3 Turkey Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
9.4 Egypt Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
9.5 South Africa Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oral Polio Vaccines (OPV) Sales and Market Share by Type (2015-2020)
10.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Type (2015-2020)
10.3 Global Oral Polio Vaccines (OPV) Price by Type (2015-2020)
11 Global Oral Polio Vaccines (OPV) Market Segment by Application
11.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2015-2020)
11.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2015-2020)
11.3 Global Oral Polio Vaccines (OPV) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oral Polio Vaccines (OPV) Sales, Revenue and Growth Rate (2021-2025)
12.2 Oral Polio Vaccines (OPV) Market Forecast by Regions (2021-2025)
12.2.1 North America Oral Polio Vaccines (OPV) Market Forecast (2021-2025)
12.2.2 Europe Oral Polio Vaccines (OPV) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oral Polio Vaccines (OPV) Market Forecast (2021-2025)
12.2.4 South America Oral Polio Vaccines (OPV) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oral Polio Vaccines (OPV) Market Forecast (2021-2025)
12.3 Oral Polio Vaccines (OPV) Market Forecast by Type (2021-2025)
12.3.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Type (2021-2025)
12.3.2 Global Oral Polio Vaccines (OPV) Market Share Forecast by Type (2021-2025)
12.4 Oral Polio Vaccines (OPV) Market Forecast by Application (2021-2025)
12.4.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Application (2021-2025)
12.4.2 Global Oral Polio Vaccines (OPV) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oral Polio Vaccines (OPV) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Polio Vaccines (OPV) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Oral Polio Vaccines (OPV) Major Business
Table 9. Sanofi Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Oral Polio Vaccines (OPV) Product and Services
Table 12. Sanofi Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Major Business
Table 15. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 16. Halfkin Bio-Pharmaceuticals SWOT Analysis
Table 17. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
Table 18. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute Oral Polio Vaccines (OPV) Major Business
Table 21. Serum Institute Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 22. Serum Institute SWOT Analysis
Table 23. Serum Institute Oral Polio Vaccines (OPV) Product and Services
Table 24. Serum Institute Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GSK Basic Information, Manufacturing Base and Competitors
Table 26. GSK Oral Polio Vaccines (OPV) Major Business
Table 27. GSK Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 28. GSK SWOT Analysis
Table 29. GSK Oral Polio Vaccines (OPV) Product and Services
Table 30. GSK Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Oral Polio Vaccines (OPV) Major Business
Table 33. Bio-Med Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 34. Bio-Med SWOT Analysis
Table 35. Bio-Med Oral Polio Vaccines (OPV) Product and Services
Table 36. Bio-Med Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bibcol Basic Information, Manufacturing Base and Competitors
Table 38. Bibcol Oral Polio Vaccines (OPV) Major Business
Table 39. Bibcol Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 40. Bibcol SWOT Analysis
Table 41. Bibcol Oral Polio Vaccines (OPV) Product and Services
Table 42. Bibcol Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Major Business
Table 45. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 46. Panacea Biotec Ltd SWOT Analysis
Table 47. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
Table 48. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 50. Tiantan Biological Oral Polio Vaccines (OPV) Major Business
Table 51. Tiantan Biological Oral Polio Vaccines (OPV) Total Revenue (USD Million) (2018-2019)
Table 52. Tiantan Biological SWOT Analysis
Table 53. Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
Table 54. Tiantan Biological Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Oral Polio Vaccines (OPV) Sales by Manufacturer (2018-2019) (M Doses)
Table 56. Global Oral Polio Vaccines (OPV) Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Oral Polio Vaccines (OPV) Sales by Regions (2015-2020) (M Doses)
Table 58. Global Oral Polio Vaccines (OPV) Sales Market Share by Regions (2015-2020)
Table 59. Global Oral Polio Vaccines (OPV) Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Oral Polio Vaccines (OPV) Sales by Countries (2015-2020) (M Doses)
Table 61. North America Oral Polio Vaccines (OPV) Sales Market Share by Countries (2015-2020)
Table 62. North America Oral Polio Vaccines (OPV) Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Oral Polio Vaccines (OPV) Revenue Market Share by Countries (2015-2020)
Table 64. Europe Oral Polio Vaccines (OPV) Sales by Countries (2015-2020) (M Doses)
Table 65. Europe Oral Polio Vaccines (OPV) Sales Market Share by Countries (2015-2020)
Table 66. Europe Oral Polio Vaccines (OPV) Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Regions (2015-2020) (M Doses)
Table 68. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Oral Polio Vaccines (OPV) Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Oral Polio Vaccines (OPV) Sales by Countries (2015-2020) (M Doses)
Table 71. South America Oral Polio Vaccines (OPV) Sales Market Share by Countries (2015-2020)
Table 72. South America Oral Polio Vaccines (OPV) Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Oral Polio Vaccines (OPV) Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Countries (2015-2020) (M Doses)
Table 75. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Market Share by Countries (2015-2020)
Table 78. Global Oral Polio Vaccines (OPV) Sales by Type (2015-2020) (M Doses)
Table 79. Global Oral Polio Vaccines (OPV) Sales Share by Type (2015-2020)
Table 80. Global Oral Polio Vaccines (OPV) Revenue by Type (2015-2020) (USD Million)
Table 81. Global Oral Polio Vaccines (OPV) Revenue Share by Type (2015-2020)
Table 82. Global Oral Polio Vaccines (OPV) Sales by Application (2015-2020) (M Doses)
Table 83. Global Oral Polio Vaccines (OPV) Sales Share by Application (2015-2020)
Table 84. Global Oral Polio Vaccines (OPV) Sales Forecast by Regions (2021-2025) (M Doses)
Table 85. Global Oral Polio Vaccines (OPV) Market Share Forecast by Regions (2021-2025)
Table 86. Global Oral Polio Vaccines (OPV) Sales Forecast by Type (2021-2025) (M Doses)
Table 87. Global Oral Polio Vaccines (OPV) Market Share Forecast by Type (2021-2025)
Table 88. Global Oral Polio Vaccines (OPV) Sales Forecast by Application (2021-2025)
Table 89. Global Oral Polio Vaccines (OPV) Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oral Polio Vaccines (OPV) Picture
Figure 2. Global Sales Market Share of Oral Polio Vaccines (OPV) by Type in 2019
Figure 3. Trivalent OPV Picture
Figure 4. Bivalent OPV Picture
Figure 5. Oral Polio Vaccines (OPV) Sales Market Share by Application in 2018
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Oral Polio Vaccines (OPV) Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Oral Polio Vaccines (OPV) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturer in 2019
Figure 29. Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Oral Polio Vaccines (OPV) Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Oral Polio Vaccines (OPV) Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 34. Global Oral Polio Vaccines (OPV) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Oral Polio Vaccines (OPV) Revenue Market Share by Regions (2015-2020)
Figure 36. Global Oral Polio Vaccines (OPV) Revenue Market Share by Regions in 2018
Figure 37. North America Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
Figure 38. Europe Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
Figure 40. South America Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020)
Figure 42. North America Oral Polio Vaccines (OPV) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Oral Polio Vaccines (OPV) Sales Market Share by Countries (2015-2020)
Figure 44. North America Oral Polio Vaccines (OPV) Sales Market Share by Countries in 2018
Figure 45. North America Oral Polio Vaccines (OPV) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Oral Polio Vaccines (OPV) Revenue Market Share by Countries in 2018
Figure 47. United States Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 48. Canada Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 49. Mexico Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 50. Europe Oral Polio Vaccines (OPV) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Countries in 2019
Figure 53. Germany Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 54. UK Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 55. France Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 56. Russia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 57. Italy Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 58. Asia-Pacific Oral Polio Vaccines (OPV) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Regions 2019
Figure 61. China Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 62. Japan Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 63. Korea Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 64. India Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 65. Southeast Asia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 66. South America Oral Polio Vaccines (OPV) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Oral Polio Vaccines (OPV) Sales Market Share by Countries in 2019
Figure 68. South America Oral Polio Vaccines (OPV) Revenue Market Share by Countries in 2019
Figure 69. Brazil Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 70. Argentina Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 71. Middle East and Africa Oral Polio Vaccines (OPV) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 76. Egypt Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 77. Turkey Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 78. South Africa Oral Polio Vaccines (OPV) Sales and Growth Rate (2015-2020) (M Doses)
Figure 79. Global Oral Polio Vaccines (OPV) Sales and Growth Rate (2021-2025) (M Doses)
Figure 80. Global Oral Polio Vaccines (OPV) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Oral Polio Vaccines (OPV) Market Forecast (2021-2025) (M Doses)
Figure 82. Europe Sales Oral Polio Vaccines (OPV) Market Forecast (2021-2025) (M Doses)
Figure 83. Asia-Pacific Sales Oral Polio Vaccines (OPV) Market Forecast (2021-2025) (M Doses)
Figure 84. South America Sales Oral Polio Vaccines (OPV) Market Forecast (2021-2025) (M Doses)
Figure 85. Middle East & Africa Sales Oral Polio Vaccines (OPV) Market Forecast (2021-2025) (M Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
経口ワクチンの世界市場 2020年 Market Overview The Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- ポリオワクチンの世界市場 2020年 Market Overview The Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 鳥インフルエンザワクチンの世界市場 2020年 Market Overview The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 新興がん用ワクチンの世界市場 2020年 Market Overview The global Emerging Cancer Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Emerging Cancer Vacc…